Latest Revenue Growth News

PGG Wrightson posted a robust FY26 with $1.1 billion revenue and a 46% jump in net profit, driven by strong livestock prices and strategic acquisitions.

ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.

News Corp’s FY26 revenue rose 7% to $9.03 billion, driven by Digital Real Estate Services and Dow Jones, while net income from continuing operations increased 15% to $743 million.

Integral Diagnostics (ASX: IDX) posted strong preliminary FY26 results with revenue nearing $790 million and operating EBITDA up 30%, while announcing Jenny Martin as incoming CFO amid leadership transitions.

Tabcorp Holdings has agreed to acquire BetMakers Technology Group for approximately $267 million, aiming to accelerate its wagering technology upgrade and expand its global B2B footprint. The deal targets $30 million in cost synergies by Year 2 and expects double-digit EPS accretion by Year 3.

CAR Group Limited reported a 14% increase in net profit after tax to AUD 332.4 million for FY26, driven by strong revenue growth and AI innovation across its global vehicle marketplaces.

News Corp posted a 7% revenue increase to $9.028 billion in fiscal 2026, driven by gains across its key segments, while net income attributable to stockholders fell 51% due to absence of prior discontinued operations income.

Metcash Limited posted a steady FY26 performance, with group revenue rising to $19.6 billion and EBITDA up 1.9%, driven by growth in Food and digital channels despite challenges in Hardware.

Resmed delivered a strong FY2026 with 10% revenue growth to $5.7 billion, a 17% rise in non-GAAP EPS, and a 10% dividend hike. Strategic moves include selling MatrixCare and acquiring Noctrix Health.

AVITA Medical posted robust Q2 2026 results with 18% revenue growth, driven by RECELL and supported by Cohealyx and PermeaDerm, and now expects to reach cash flow breakeven by year-end.

Nick Scali Limited posted a 31% jump in net profit after tax to $75.7 million for FY26, driven by margin gains and UK sales recovery, and announced a fully franked final dividend of 39 cents per share.

ReNerve has secured marketing approval for its NervAlign® Nerve Cuff in the Philippines, tapping into a major Southeast Asian market with significant nerve injury demand.